STZ
32
3
HCP
49
4
MNST
59
2
BRK.B
40
-2
GLW
52
3
ADT
38
3
FOXA
69
2
GRMN
50
2
PWR
41
-2
PPL
54
-5
USB
61
6
RHI
29
6
V
70
-2
CVS
70
-2
HUM
33
3
MAC
44
-2
VTR
60
5
MTCH
57
6
T
68
2
AN
58
4
STZ
32
3
HCP
49
4
MNST
59
2
BRK.B
40
-2
GLW
52
3
ADT
38
3
FOXA
69
2
GRMN
50
2
PWR
41
-2
PPL
54
-5
USB
61
6
RHI
29
6
V
70
-2
CVS
70
-2
HUM
33
3
MAC
44
-2
VTR
60
5
MTCH
57
6
T
68
2
AN
58
4
Financhill
Back

Matinas BioPharma Holdings Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
29

MTNB
Matinas BioPharma Holdings

Last Price:
$0.61
Seasonality Move:
9.06%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.33
Seasonality Move:
1.75%
Sell
29
Matinas BioPharma Holdings (MTNB) is a Sell

Is Matinas BioPharma Holdings a Buy, Sell or Hold?

  • The current Matinas BioPharma Holdings [MTNB] share price is $0.61. The Score for MTNB is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • MTNB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MTNB Stock Price Chart

What is Matinas BioPharma Holdings's stock price today?

  • The Matinas BioPharma Holdings share price today is $0.61
    The current trend is relatively stagnant and MTNB is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

MTNB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 49.22 Sell
Chaikin Money Flow: -698814 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.57 - 0.63) Buy
Bollinger Bands (100): (0.12 - 2.64) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

MTNB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.6 Buy
20-day SMA: 0.6 Buy
50-day SMA: 0.6 Buy
200-day SMA: 4.33 Sell
8-day EMA: 0.6 Buy
20-day EMA: 0.6 Buy
50-day EMA: 0.8 Sell
200-day EMA: 4.12 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Matinas BioPharma Holdings Earnings Growth & MTNB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.56 per share, and a decrease next year of $2.50 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Matinas BioPharma Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):